Halozyme Therapeutics Inc (HALO): Cost of Product Sales

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	4
Posts	398
Boards Moderated	0
Alias Born	06/21/2006

friendofthedevil

Re: None

Tuesday, 08/12/2014 2:13:43 AM

Tuesday, August 12, 2014 2:13:43 AM

Cost of Product Sales – Cost of product sales were $5.9 million for the three months ended June 30, 2014 compared to $1.3 million for the three months ended June 30, 2013 . The increase of $4.6 million in cost of product sales was due to the cost of product sales related to bulk rHuPH20 product sales for Roche collaboration products.

Cost of Product Sales – Cost of product sales were $11.4 million for the six months ended June 30, 2014 compared to $2.0 million for the six months ended June 30, 2013 . The increase of $9.4 million in cost of product sales was due to the cost of product sales related to bulk rHuPH20 product sales for Roche collaboration products.

But: Research and development expenses relating to our Enhanze collaborations for the six months ended June 30, 2014 decreased by 78%, compared to the same period in 2013 primarily due to capitalizing as inventory $9.7 million of the manufacturing costs for Roche collaboration products in the current period...

Rod, you said you were keeping an eye on this. Do you have a feel for how much Herceptin and MabThera this translates to?